Donanemab and lecanemab in Alzheimer's disease treatment: A narrative review of clinical trials and discussion of implications for patient access. // Equity Neuroscience. – URL: https://www.sciencedirect.com/science/article/pii/S3050840126000383?dgcid=rss_sd_all
Donanemab and lecanemab in Alzheimer's disease treatment: A narrative review of clinical trials and discussion of implications for patient access. Equity Neuroscience. https://www.sciencedirect.com/science/article/pii/S3050840126000383?dgcid=rss_sd_all
“Donanemab and lecanemab in Alzheimer's disease treatment: A narrative review of clinical trials and discussion of implications for patient access.” Equity Neuroscience.
@article{article8800,
title = {Donanemab and lecanemab in Alzheimer's disease treatment: A narrative review of clinical trials and discussion of implications for patient access},
journal = {Equity Neuroscience},
url = {https://www.sciencedirect.com/science/article/pii/S3050840126000383?dgcid=rss_sd_all}
}